Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000053417-25-000086·Arcutis Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Common Stock · CUSIP: 03969K108
Event date: 2025-09-30
- Filing-level shares
- 12,254,119
- Percent of class
- 10.2%
- Jennison Associates LLC
Shares: 12,254,119 · Class: 10.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-25-000086
- Form type
- SCHEDULE 13G/A
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Oct 06, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership